Q2 FY2026 · ended Jun 30, 2026 · Revenue $15.33M, -24.7% YoY · Filed Aug 19, 2026
Solesence, Inc. (SLSN) files with the SEC under industry code 2844, Perfumes, Cosmetics & Other Toilet Preparations. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $15.3 million and a net loss of $158,000. As of Jun 30, 2026 it held $1.0 million in cash and investments and $8.4 million in total debt.
Revenue
$15.33M
-24.7% vs year-ago quarter
Net income
$-158,000
-104.9% vs year-ago quarter
Operating cash flow
$191,000
+129.2% vs year-ago quarter
Free cash flow
$-404,000
-114.4% vs prior quarter
EPS
$0.00
-100.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
70.65M
+0.2% vs year-ago quarter
Net cash
$-7.37M
Q2 FY2026
Operating margin
-3.6%
TTM
Company profile
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
- Listed as
- SLSN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Romeoville, IL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 883107
- Former names
- NANOPHASE TECHNOLOGIES Corp (until Mar 31, 2025); NANOPHASE TECHNOLOGIES CORPORATION (until Feb 1, 2016)
Other Perfumes, Cosmetics & Other Toilet Preparations companies
- Colgate Palmolive Co CL
- Haleon plc HLN
- Estee Lauder Companies Inc EL
- e.l.f. Beauty, Inc. ELF
- Interparfums Inc IPAR
- Coty Inc. COTY
- EDGEWELL PERSONAL CARE Co EPC
- Oddity Tech Ltd ODD
All 22 Perfumes, Cosmetics & Other Toilet Preparations companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $15.3M | $13.0M | $12.5M | $14.6M | $20.4M |
| Operating income | $121,000 | -$700,000 | $186,000 | -$781,000 | $2.5M |
| Net income | -$158,000 | -$962,000 | $163,000 | -$1.1M | $3.2M |
| Diluted EPS | $0.00 | -$0.01 | $0.00 | -$0.02 | $0.04 |
| Operating cash flow | $191,000 | $1.5M | $1.8M | -$2.5M | -$654,000 |
| Total assets | $46.4M | $44.0M | $46.5M | $54.0M | $60.0M |
| Stockholders' equity | $13.2M | $13.2M | $14.1M | $17.2M | $14.4M |
| Cash and investments | $1.0M | $573,000 | $1.3M | $429,000 | $4.1M |
| Total debt | $8.4M | $8.7M | $9.1M | $9.4M | $9.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Oct 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 2, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Restatement
|
Aug 21, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 20, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Aug 19, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 10, 2026 | Jul 6, 2026 |
All 1000 Solesence, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.